Article

125 views
KEY POINTS Tech giants are bringing automation and robotics to tackle mosquito-borne diseases. Besides genetically engineered mosquitoes, machine learning and ...
Authentic, Ad-free Reporting
High-quality, Exclusive Content
Original Market Research Reports
Original Resources & Databases
Global Surveys & Guidelines
Lowest Subscription Pricing

Healthcare News You Won't Read Elsewhere

Most up-to-date information, original and in-depth reviews, full-length exclusive market reports and forecasts, full-access to the smart knowledge base centres, useful resources and databases.

Access articles & resources worth up to $4000.

KEY POINTS Tech giants are bringing automation and robotics to tackle mosquito-borne diseases. Besides genetically engineered mosquitoes, machine learning and ...

You have read of your 8 free articles this month.

Subscribe to
Medgenera All-Access

Enjoy unlimited access to all contents, resources, exclusive market research reports, databases, surveys and many more features by subscribing to Medgenera All-Access.

Access articles & resources worth up to US $4, 000 per month.

Authentic, Ad-free Reporting
High-quality, Exclusive Content
Original Market Research Reports
Original Resources & Databases
Global Surveys & Guidelines
Lowest Subscription Pricing

Healthcare News You Won't Read Elsewhere

Most up-to-date information, original and in-depth reviews, full-length exclusive market reports and forecasts, full-access to the smart knowledge base centres, useful resources and databases.

Access articles & resources worth up to $4000.

More in Artificial Intelligence


ARTIFICIAL INTELLIGENCE

AI-Based Pharma Startup BenevolentAI worth $2 Billion Raises $115 M Funding

UK-based BenevolentAI raised one of the largest fundings in AI pharmaceutical field. The company is significantly disrupting the pharma industry which spends $180 billion in a year on R&D.

Artificial Intelligence

First AI-Based Diabetic Retinopathy Detection Device Gets FDA Approval

The artificial intelligence (AI) based device called IDx-DR received US FDA approval for the screening of diabetic retinopathy- a common eye disease in diabetic patients that could lead to vision impairment and blindness.

Artificial Intelligence

AI-Based Software EyeArt™ in Smartphone Could Prevent Vision Loss in 90% Diabetic People

KEY POINTS One in five diabetic Indians is at risk of developing diabetic retinopathy, which can lead to blindness. Eyenuk’s ...

Artificial Intelligence

Tech, Biotech Giants Deploying AI to Catch Zika and Dengue Mosquitoes

KEY POINTS Tech giants are bringing automation and robotics to tackle mosquito-borne diseases. Besides genetically engineered mosquitoes, machine learning and ...

Most Popular


GROW

7 New Ideas to Start a Healthcare Business in India (2018)

Seven new #healthcare #business ideas in India in 2018. Which one would you prefer to pursue?

NEWLY PUBLISHED

Pharma Patents: Can India Reward Incremental Innovation?

Chandramouli Natarajan is an Associate Scientist, Ricon pharma LLC, Denville, USA. He has presented his opinion and views on the Pharmaceutical patents issues in India. This article is available for free to read and share.